Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world settingTakuya Sho, Naoya Sakamoto, Akihisa Nakamura et al.|JGH Open|2019Cited by 45
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteriaTakuya Sho, Naoya Sakamoto, Goki Suda et al.|Hepatology Research|2020Cited by 44
Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinomaSeiji Tsunematsu, Naoya Sakamoto, Makoto Chuma et al.|Abdominal Imaging|2015Cited by 37
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionNaoya Sakamoto, Goki Suda, Chitomi Hasebe et al.|Journal of Gastroenterology|2019Cited by 27
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura et al.|Journal of Gastroenterology|2018Cited by 22